Creative Planning Has $9.32 Million Position in iShares Biotechnology ETF (NASDAQ:IBB)

Creative Planning raised its position in iShares Biotechnology ETF (NASDAQ:IBB) by 2.9% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 67,902 shares of the financial services provider’s stock after buying an additional 1,905 shares during the quarter. Creative Planning’s holdings in iShares Biotechnology ETF were worth $9,320,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in the company. Dorsey & Whitney Trust CO LLC bought a new position in iShares Biotechnology ETF during the fourth quarter worth about $206,000. Oppenheimer & Co. Inc. increased its holdings in shares of iShares Biotechnology ETF by 4.0% during the fourth quarter. Oppenheimer & Co. Inc. now owns 33,215 shares of the financial services provider’s stock worth $4,512,000 after purchasing an additional 1,273 shares during the period. Gray Foundation acquired a new stake in shares of iShares Biotechnology ETF in the fourth quarter valued at approximately $17,890,000. XML Financial LLC boosted its stake in shares of iShares Biotechnology ETF by 9.2% in the fourth quarter. XML Financial LLC now owns 3,016 shares of the financial services provider’s stock valued at $410,000 after buying an additional 255 shares during the period. Finally, Humankind Investments LLC acquired a new stake in iShares Biotechnology ETF during the fourth quarter worth approximately $611,000. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Down 0.6 %

Shares of NASDAQ IBB opened at $144.77 on Wednesday. iShares Biotechnology ETF has a fifty-two week low of $111.83 and a fifty-two week high of $150.57. The business has a fifty day moving average price of $145.68 and a two-hundred day moving average price of $138.97.

iShares Biotechnology ETF Dividend Announcement

The company also recently disclosed a dividend, which was paid on Monday, September 30th. Shareholders of record on Wednesday, September 25th were paid a dividend of $0.2005 per share. The ex-dividend date of this dividend was Wednesday, September 25th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.